Broadwood Partners challenges STAAR Surgical deal with Alcon

Go back to Broadwood Partners challenges STAAR Surgical deal with Alcon

Broadwood Partners Questions Integrity of STAAR Surgical’s Last-Minute Forecast Change and Fairness Opinion in Sale to Alcon

October 8, 2025 8:00 AM UTC

Conflicted Management Team Sharply Revised Its Financial Projections Downward Just Days Before Board Vote on Sale to Alcon

Continues to Urge STAAR Shareholders to Vote AGAINST the Proposed Transaction

NEW YORK--(BUSINESS WIRE)-- Broadwood Partners, L.P. and its affiliates (Broadwood or we) today sent the following letter to the shareholders of STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA). Broadwood, which owns 27.5% of STAARs outstanding common shares, continues to urge its fellow shareholders to vote on its GREEN Proxy Card... More